A mathematical model of the transition from the normal hematopoiesis to the chronic and acceleration-acute stages in myeloid leukemia

[1] Rubinow, S.I.; Lebowitz, J.L. A mathematical model of neutrophil production and control in normal man. J. Math. Biol. 1975, 1, 187–225. [Google Scholar] [CrossRef]
[2] Rubinow, S.I.; Lebowitz, J.L. A mathematical model of the acute myeloblastic leukemic state in man. Biophys. J. 1976, 16, 897–910. [Google Scholar] [CrossRef]
[3] Mackey, M.C.; Glass, L. Oscillation and chaos in physiological control systems. Science 1977, 197, 287–289. [Google Scholar] [CrossRef]
[4] Mackey, M.C. Unified hypothesis of the origin of aplastic anemia and periodic hematopoiesis. Blood 1978, 51, 941–956. [Google Scholar] [CrossRef]
[5] Djulbegovic, B.; Svetina, S. Mathematical model of acute myeloblastic leukaemia: An investigation of the relevant kinetic parameters. Cell Prolif. 1985, 18, 307–319. [Google Scholar] [CrossRef]
[6] Fokas, A.S.; Keller, J.B.; Clarkson, B.D. Mathematical model of granulocytopoiesis and chronic myelogenous leukemia. Cancer Res. 1991, 51, 2084–2091. [Google Scholar]
[7] Neiman, B. A Mathematical Model of Chronic Myelogenous Leukemia; Oxford University: Oxford, UK, 2000; Available online: https://core.ac.uk/download/files/69/96488.pdf (accessed on 10 May 2019).
[8] Andersen, L.K.; Mackey, M.C. Resonance in periodic chemotherapy: A case study of acute myelogenous leukemia. J. Theor. Biol. 2001, 209, 113–130. [Google Scholar] [CrossRef]
[9] Colijn, C.; Mackey, M.C. A mathematical model of hematopoiesis-I. Periodic chronic myelogenous leukemia. J. Theor. Biol. 2005, 237, 117–132. [Google Scholar] [CrossRef]
[10] Adimy, M.; Crauste, F.; Ruan, S. A mathematical study of the hematopoiesis process with applications to chronic myelogenous leikemia. SIAM J. Appl. Math. 2005, 65, 1328–1352. [Google Scholar] [CrossRef]
[11] Dingli, D.; Michor, F. Successful therapy must eradicate cancer stem cells. Stem Cells 2006, 24, 2603–2610. [Google Scholar] [CrossRef]
[12] Kim, P.S.; Lee, P.P.; Levy, D. Dynamics and potential impact of the immune response to chronic myelogenous leukemia. PLoS Comput. Biol. 2008, 4, e1000095. [Google Scholar] [CrossRef] [PubMed]
[13] Cucuianu, A.; Precup, R. A hypothetical-mathematical model of acute myeloid leukemia pathogenesis. Comput. Math. Methods Med. 2010, 11, 49–65. [Google Scholar] [CrossRef]
[14] Doumic-Jauffret, M.; Kim, P.S.; Perthame, B. Stability analysis of a simplified yet complete model for chronic myelogenous leukemia. Bull. Math. Biol. 2010, 72, 1732–1759. [Google Scholar] [CrossRef] [PubMed]
[15] Komarova, N.L. Mathematical modeling of cyclic treatments of chronic myeloid leukemia. Math. Biosci. Eng. 2011, 8, 289–306. [Google Scholar]
[16] Stiehl, T.; Marciniak-Czochra, A. Mathematical modelling of leukemogenesis and cancer stem cell dynamics. Math. Mod. Nat. Phenom. 2012, 7, 166–202. [Google Scholar] [CrossRef]
[17] MacLean, A.L.; Lo Celso, C.; Stumpf, M.P.H. Population dynamics of normal and leukaemia stem cells in the haematopoietic stem cell niche show distinct regimes where leukaemia will be controlled. J. R. Soc. Interfaces 2013, 10, 20120968. [Google Scholar] [CrossRef]
[18] MacLean, A.L.; Filippi, S.; Stumpf, M.P.H. The ecology in the hematopoietic stem cell niche determines the clinical outcome in chronic myeloid leukemia. Proc. Natl. Acad. Sci. USA 2014, 111, 3882–3888. [Google Scholar] [CrossRef]
[19] Radulescu, I.R.; Candea, D.; Halanay, A. A study on stability and medical implications for a complex delay model for CML with cell competition and treatment. J. Theor. Biol. 2014, 363, 30–40. [Google Scholar] [CrossRef]
[20] Bianca, C.; Pennisi, M.; Motta, S.; Ragusa, M.A. Immune system network and cancer vaccine. AIP Conf. Proc. 2011, 1389, 945–948. [Google Scholar]
[21] Bianca, C.; Pappalardo, F.; Pennisi, M.; Ragusa, M.A. Persistence analysis in a Kolmogorov-type model for cancer-immune system competition. AIP Conf. Proc. 2013, 1558, 1797–1800. [Google Scholar]
[22] Ragusa, M.A.; Russo, G. ODEs approaches in modeling fibrosis: Comment on “Towards a unified approach in the modeling of fibrosis: A review with research perspectives” by Martine Ben Amar and Carlo Bianca. Phys. Life Rev. 2016, 17, 112–113. [Google Scholar] [CrossRef] [PubMed]
[23] Vincent, P.C.; Rutzen-Loesevitz, L.; Tibken, B.; Heinze, B.; Hofer, E.P.; Fliedner, T.M. Relapse in chronic myeloid leukemia after bone marrow transplantation: Biomathematical modeling as a new approach to understanding pathogenesis. Stem Cells 1999, 17, 9–17. [Google Scholar] [CrossRef] [PubMed]
[24] De Conde, R.; Kim, P.S.; Levy, D.; Lee, P.P. Post-transplantation dynamics of the immune response to chronic myelogenous leukemia. J. Theor. Biol. 2005, 236, 39–59. [Google Scholar] [CrossRef] [PubMed]
[25] Kim, P.S.; Lee, P.P.; Levy, D. Mini-Transplants for Chronic Myelogenous Leukemia: A Modeling Perspective, Biology and Control Theory: Current Challenges; Lecture Notes in Control and Information Sciences; Springer: Berlin/Heidelberg, Germany, 2007; Volume 357, pp. 3–20. [Google Scholar]
[26] Marciniak-Czochra, A.; Stiehl, T. Mathematical models of hematopoietic reconstitution after stem cell transplantation. In Model Based Parameter Estimation: Theory and Applications; Bock, H.G., Carraro, T., Jaeger, W., Koerkel, S., Rannacher, R., Schloeder, J.P., Eds.; Springer: Berlin/Heidelberg, Germany, 2007; pp. 191–206. [Google Scholar]
[27] Precup, R.; Arghirescu, S.; Cucuianu, A.; Serban, M. Mathematical Modeling of cell dynamics after allogeneic bone marrow transplantation. Int. J. Biomath. 2012, 5, 1–18. [Google Scholar] [CrossRef]
[28] Precup, R.; Serban, M.A.; Trif, D. Asymptotic stability for a model of cellular dynamics after allogeneic bone marrow transplantation. Nonlinear Dyn. Syst. Theory 2013, 13, 79–92. [Google Scholar]
[29] Precup, R. Mathematical understanding of the autologous stem cell transplantation. Ann. Tiberiu Popoviciu Semin. Funct. Equ. Approx. Convexity 2012, 10, 155–167. [Google Scholar]
[30] Stiehl, T.; Ho, A.; Marciniak-Czochra, A. The impact of CD34+ cell dose on engraftment after SCTs: Personalized estimates based on mathematical modeling. Bone Marrow Transpl. 2014, 49, 30–37. [Google Scholar] [CrossRef]
[31] Afenya, E. Mathematical models for cancer and their relevant insights. In Handbook of Cancer Models with Applications; Tan, W.Y., Hanin, L., Eds.; World Scientific: Hackensack, NJ, USA, 2008. [Google Scholar]
[32] Michor, F. Mathematical models of cancer stem cells. J. Clin. Oncol. 2008, 26, 2854–2861. [Google Scholar] [CrossRef]
[33] Foley, C.; Mackey, M.C. Dynamic hematological disease: A review. J. Math. Biol. 2009, 58, 285–322. [Google Scholar] [CrossRef]
[34] Clapp, G.; Levy, D. A review of mathematical models for leukemia and lymphoma. Drug Discov. Today Dis. Models 2015, 16, 1–6. [Google Scholar] [CrossRef]
[35] Jilkine, A.; Gutenkunst, R. Effect of dedifferentiation on time to mutation acquisition in stem cell-driven cancers. PLoS Comput. Biol. 2014, 10, e1003481. [Google Scholar] [CrossRef] [PubMed]
[36] Driessens, G.; Beck, B.; Caauwe, A.; Simons, B.; Blanpain, C. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488, 527–530. [Google Scholar] [CrossRef] [PubMed]
[37] Klein, A.; Simons, B. Universal patterns of stem cell fate in cycling adult tissues. Development 2011, 138, 3103–3111. [Google Scholar] [CrossRef] [PubMed]
[38] Lopez-Garcia, C.; Klein, A.; Simons, B.; Winton, D. Intestinal stem cell replacement follows a pattern of neutral drift. Science 2010, 330, 822–825. [Google Scholar] [CrossRef] [PubMed]
[39] Snippert, H.; van der Flier, L.; Sato, T.; van Es, J.; van den Born, M.; Kroon-Veenboer, C.; Barker, N.; Klein, A.; van Rheenen, J.; Simons, B.; et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 2010, 143, 134–144. [Google Scholar] [CrossRef] [PubMed]
[40] Gou, X.C.; Kong, D.; Tang, X. Contradictory relationships between cancer and normal cells and implications for anti-cancer therapy. Asian Pac. J. Cancer Prev. 2015, 16, 5143–5147. [Google Scholar] [CrossRef] [PubMed]
[41] Precup, R.; Serban, M.A.; Trif, D.; Cucuianu, A. A planning algorithm for correction therapies after allogeneic stem cell transplantation. J. Math. Model. Algorithm 2012, 11, 309–323. [Google Scholar] [CrossRef]
[42] Michor, F.; Hughes, T.P.; Iwasa, Y.; Branford, S.; Shah, N.P.; Sawyers, C.L.; Nowak, M.A. Dynamics of chronic myeloid leukaemia. Nature 2005, 435, 1267–1270. [Google Scholar] [CrossRef]
[43] Howard, M.; Hamilton, P.; Britton, R. Haematology; Churchill Livingstone: London, UK, 2013; pp. 10–120. [Google Scholar]
[44] Young, N. Clinical Hematology; Mosby Elsevier: Philadelphia, PA, USA, 2006; pp. 1035–1456. [Google Scholar]
[45] Kaushansky, K.; Lichtman, M.A.; Beutler, E.; Kipps, T.J.; Seligsohn, U.; Prchal, J.T. Williams Hematology; McGraw-Hill Medical: New York, NY, USA, 2010; pp. 1150–2439. [Google Scholar]
[46] Kawamoto, H.; Wada, H.; Katsura, Y. A revised scheme for developmental pathways of hematopoietic cells: The myeloid-based model. Int. Immunol. 2010, 22, 65–70. [Google Scholar] [CrossRef]
[47] Abkowitz, J.L. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 2002, 100, 2665–2667. [Google Scholar] [CrossRef]
[48] Ramalingam, P.; Poulos, M.; Butler, J. Regulation of the hematopoietic stem cell lifecycle by the endothelial niche. Comput. Curr. Opin. Hematol. 2017, 24, 289–299. [Google Scholar] [CrossRef] [PubMed]
[49] Zon, L. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 2008, 453, 306–313. [Google Scholar] [CrossRef] [PubMed]
[50] Arber, D.; Orazi, A.; Hasserjian, R.; Thiele, J.; Borowitz, M.; Le Beau, M.; Bloomfield, C.; Cazzola, M.; Vardiman, J. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016, 127, 2391–2405. [Google Scholar] [CrossRef] [PubMed]
[51] Roeder, I.; d’Inverno, M. New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia. Blood Cells Mol. Dis. 2009, 43, 88–97. [Google Scholar] [CrossRef] [PubMed]
[52] Hemminki, K.; Jiang, Y. Familial myeloid leukemias from the Swedish Family-Cancer Database. Leuk. Res. 2002, 26, 611–613. [Google Scholar] [CrossRef]
[53] Kantarjian, H.; O’Brien, S.; Jabbour, E.; Garcia-Manero, G.; Quintas-Cardama, A.; Shan, J.; Rios, M.; Ravandi, F.; Faderl, S.; Kadia, T.; et al. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: A single-institution historical experience. Blood 2012, 119, 1981–1987. [Google Scholar] [CrossRef]
[54] Thomas, E. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Intern. Med. 1986, 104, 155–163. [Google Scholar] [CrossRef]
[55] Alenzi, F.Q.; Alenazi, B.Q.; Ahmad, S.Y.; Salem, M.L.; Al-Jabri, A.A.; Wyse, R.K.H. The haemopoietic stem cell: Between apoptosis and self renewal. Yale J. Biol. Med. 2009, 82, 7–18. [Google Scholar]
[56] Cisneros, T.; Dillard, D.; Castro, M.; Arredondo-Guerrero, J.; Krams, S.; Esquivel, C.; Martinez, O. The role of natural killer cells in recognition and killing of stem cells and stem cell-derived hepatoblasts. Am. J. Transplant 2017, 17 (Suppl. 3), 115. [Google Scholar]
[57] Domen, J. The role of apoptosis in regulating hematopoietic stem cell numbers. Apoptosis 2001, 6, 239–252. [Google Scholar] [CrossRef]
[58] Riether, C.; Schürch, C.M.; Ochsenbein, A.F. Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ. 2015, 22, 187–198. [Google Scholar] [CrossRef] [PubMed]
[59] Vivier, E.; Tomasello, E.; Baratin, M.; Walzer, T.; Ugolini, S. Functions of natural killer cells. Nat. Immunol. 2008, 9, 503–510. [Google Scholar] [CrossRef] [PubMed]
[60] Kaplan, D.; Glass, L. Understanding Nonlinear Dynamics; Springer: New York, NY, USA, 1995. [Google Scholar]
[61] Coddington, E.A.; Levinson, N. Theory of Ordinary Differential Equations; Tata McGraw-Hill: New Delhi, India, 1972. [Google Scholar]
[62] Jones, D.S.; Plank, M.J.; Sleeman, B.D. Differential Equations and Mathematical Biology; CRC Press: London, UK, 2010. [Google Scholar]
[63] Stine, R.; Matunis, E. Stem cell competition: Finding balance in the niche. Trends Cell Biol. 2013, 23, 357–364. [Google Scholar] [CrossRef] [PubMed]
[64] Catlin, S.; Busque, L.; Gale, R.; Guttorp, P.; Abkowitz, J. The replication rate of human hematopoietic stem cells in vivo. Blood 2011, 117, 4460–4466. [Google Scholar] [CrossRef] [PubMed]
[65] Wilson, A.; Laurenti, E.; Oser, G.; van der Wath, R.; Blanco-Bose, W.; Jaworski, M.; Offner, S.; Dunant, C.; Eshkind, L.; Bockamp, E.; et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135, 1118–1129. [Google Scholar] [CrossRef] [PubMed]
[66] Sieburg, H.; Rezner, B.; Muller-Sieburg, C. Predicting clonal self-renewal and extinction of hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 2011, 108, 4370–4375. [Google Scholar] [CrossRef] [PubMed]
[67] Sieburg, H.; Cattarossi, G.; Muller-Sieburg, C. Lifespan differences in hematopoietic stem cells are due to imperfect repair and unstable mean-reversion. PLoS Comput. Biol. 2013, 9, e1003006. [Google Scholar] [CrossRef]
[68] Enriquez-Navas, P.; Kam, Y.; Das, T.; Hassan, S.; Silva, A.; Foroutan, P.; Ruiz, E.; Martinez, G.; Minton, S.; Gillies, R.; et al. Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer. Sci. Transl. Med. 2016, 8, 327ra24. [Google Scholar] [CrossRef]
[69] Gerlinger, M.; Rowan, A.; Horswell, S.; Larkin, J.; Endesfelder, D.; Gronroos, E.; Martinez, P.; Matthews, N.; Stewart, A.; Tarpey, P.; et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 2012, 366, 883–892. [Google Scholar] [CrossRef]